Suggested remit - To appraise the clinical and cost effectiveness of patiromer within its marketing authorisation for treating hyperkalaemia.
 
Status In progress
Process STA pre-2018
ID number 877

Provisional Schedule

Committee meeting: 1 03 October 2018
Expected publication 06 March 2019

Project Team

Project lead Jeremy Powell

Email enquiries

Consultees

Companies sponsors Vifor Pharma
Others Department of Health
  NHS England
  NHS Cumbria CCG
  NHS Mansfield & Ashfield CCG
  Welsh Government
Patient carer groups Kidney Care UK
  Kidney Research UK
  Muslim Council of Great Britain
  National Kidney Federation
  Pumping Marvellous Foundation
  South Asian Health Foundation
  Specialised Healthcare Alliance
Professional groups Association of Renal Technologists
  British Geriatrics Society
  British Renal Society
  Renal Association
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal Pharmaceutical Society
  Royal Society of Medicine
  UK Clinical Pharmacy Association
  UK Renal Pharmacy Group

Commentators

Associated public health groups Public Health England
  Public Health Wales
Comparator companies none
General commentators Allied Health Professionals
  All Wales Therapeutics and Toxicology Centre
  Association of Renal Industries
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare Products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Alliance
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee
  Welsh Kidney Patients Association
Relevant research groups Cochrane Kidney and Transplant
  MRC Clinical Trials Unit
  National Institute for Health Research

Timeline

Key events during the development of the guidance:

Date Update
09 May 2018 Invitation to participate
11 January 2018 (00:00) Scoping workshop
21 November 2017 - 19 December 2017 Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators
21 November 2017 In progress, In progress

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance